Microdisperse cellulose powder for prevention of allergic rhinitis in children



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The data of open comparative clinical study is given according to efficiency and safety of microdisperse cellulose powder used for prevention and treatment of allergic rhinitis in children.

About the authors

N A Geppe

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

Email: geppe@mma.ru
Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

M N Snegotskaya

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

N G Kolosova

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

O U Konopelko

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

N G Mashukova

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

I M Ozerskaya

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

I M Farber

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

Department of Childhood Diseases, The I.M. Sechenov Moscow Medical Academy

References

  1. Геппе НА. Взаимосвязь аллергического ринита и других заболеваний респираторного тракта и роль антигистаминных препаратов в их терапии у детей. Вопр. совр. педиатрии. 2002, № 3, с. 56-62.
  2. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус принт». 1998, 250 с.
  3. Bousquet J., Khaltaev N., Cruz A. et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 Update. J. Allergy Clin. Immunol. 2008, v. 63 (Suppl. 86), p. 8-160, 57.
  4. Елагин Р.И. Алгоритм долговременного лечения бронхиальной астмы у детей. Материалы 3-го Международного конгресса педиатров по лечению бронхиальной астмы у детей. Consilium medicum. 2000, № 1, с. 11-21.
  5. Ильина Н.И. Аллергический ринит. Аллергия, астма и клин, иммунол. 1999, № 4, с. 20-24.
  6. Yang P. С. Investigation of the nasal mucosa in perennial allergic rhinitis with SEM and ТЕМ. Zhonghua Er. Bi Yan Hou Ke ZaZhi. 1990, v. 25 (2), p. 95-96.
  7. Stanley P.J., Wilson R., Greenstone MA. et al. Abnormal nasal mucociliary clearance in patients with rhinitis and its relationship to concomitant chest disease. Br. J. Dis. Chest. 1985, v. 79 (1), p. 77-82.
  8. Козлов B.C., Державина Л.Л., Крамной А.И. Клинико-функциональные параллели при лечении аллергического ринита мометазоном фуроатом. Вест, оторино-ларингол. 2006, № 2, с. 15-17.
  9. Josling P., Steadman S. Use of Cellulose Powder for the Treatment of Seasonal Allergic Rhinitis. J. Advances In Therapy. 2003, v. 20, No. 4, p. 32-35.
  10. Aivazis V, Bourli E., Maratou E. et al. Study of mucocilary clearance in children with allergic rhinitis, before and after a six week therapy with natural cellulose powder. J. Nea. Pediatrica. Chronica. 2005, v. 5, № 2, p. 28-32.
  11. Emberlin J.C., Lewis RA. Double blind placebo controlled cross over trial of inert cellulose powder, by nasal provocation with grass pollen to assess efficacy of the product in controlling symptoms of hay fever. J. Current. Medical. Research and Opinion. 2006, v. 22, No. 2, p. 48-54.
  12. Emberlin J. and Lewis R. A double blind placebo controlled cross over trial of cellulosepowder by nasal provocation with Der p1 and Der f1. Curr. Med. Res. Opin. 2007, v. 23, p. 2423-2431.
  13. Захаржевская ТВ., Сидоренко И.В., Трескунов В.К. и соавт. Эффективность и безопасность назального спрея «Назаваль» в профилактике и лечении персистирующего аллергического ринита. Рос. Аллергол. Журн. 2009, № 5, с. 72-86.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © Pharmarus Print Media, 2009



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies